Bank of America’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-233,500
Closed -$178M 7929
2025
Q3
$178M Sell
233,500
-168,500
-42% -$125M 0.01% 872
2025
Q2
$313M Sell
402,000
-41,600
-9% -$32.3M 0.02% 595
2025
Q1
$366M Buy
443,600
+123,500
+39% +$103M 0.03% 489
2024
Q4
$247M Buy
320,100
+59,900
+23% +$49.6M 0.02% 614
2024
Q3
$231M Buy
260,200
+59,000
+29% +$53M 0.02% 665
2024
Q2
$182M Sell
201,200
-24,500
-11% -$19.6M 0.02% 719
2024
Q1
$176M Buy
225,700
+95,200
+73% +$67.8M 0.02% 749
2023
Q4
$76.1M Sell
130,500
-240,400
-65% -$140M 0.01% 1099
2023
Q3
$199M Sell
370,900
-67,600
-15% -$34.8M 0.02% 587
2023
Q2
$206M Buy
438,500
+179,100
+69% +$75.1M 0.02% 590
2023
Q1
$89.1M Buy
259,400
+150,500
+138% +$50.8M 0.01% 1007
2022
Q4
$39.8M Buy
108,900
+13,300
+14% +$4.72M ﹤0.01% 1461
2022
Q3
$30.9M Sell
95,600
-164,700
-63% -$52.2M ﹤0.01% 1620
2022
Q2
$84.4M Sell
260,300
-102,800
-28% -$30.9M 0.01% 975
2022
Q1
$104M Buy
363,100
+215,200
+146% +$55.4M 0.01% 942
2021
Q4
$40.9M Buy
147,900
+37,100
+33% +$9.4M ﹤0.01% 1567
2021
Q3
$25.6M Sell
110,800
-88,900
-45% -$21.9M ﹤0.01% 1945
2021
Q2
$45.8M Buy
199,700
+181,400
+991% +$36.4M ﹤0.01% 1422
2021
Q1
$3.42M Sell
18,300
-21,400
-54% -$4.19M ﹤0.01% 3774
2020
Q4
$6.7M Buy
39,700
+26,200
+194% +$3.91M ﹤0.01% 2870
2020
Q3
$2M Hold
13,500
﹤0.01% 3681
2020
Q2
$2.22M Sell
13,500
-36,200
-73% -$5.56M ﹤0.01% 3542
2020
Q1
$6.89M Buy
49,700
+17,500
+54% +$2.4M ﹤0.01% 2384
2019
Q4
$4.23M Sell
32,200
-56,800
-64% -$6.58M ﹤0.01% 3392
2019
Q3
$9.95M Sell
89,000
-74,500
-46% -$8.29M ﹤0.01% 2521
2019
Q2
$18.1M Sell
163,500
-1,555,100
-90% -$183M ﹤0.01% 1955
2019
Q1
$223M Buy
1,718,600
+1,658,400
+2,755% +$202M 0.03% 436
2018
Q4
$6.97M Sell
60,200
-182,100
-75% -$20.3M ﹤0.01% 2654
2018
Q3
$26M Buy
242,300
+181,000
+295% +$18.1M ﹤0.01% 1617
2018
Q2
$5.23M Sell
61,300
-500
-0.8% -$41.1K ﹤0.01% 3116
2018
Q1
$4.78M Sell
61,800
-175,500
-74% -$14.1M ﹤0.01% 3134
2017
Q4
$20M Sell
237,300
-223,200
-48% -$19M ﹤0.01% 1791
2017
Q3
$39.4M Buy
460,500
+165,400
+56% +$13.6M 0.01% 1325
2017
Q2
$24.3M Sell
295,100
-505,200
-63% -$41.2M ﹤0.01% 1567
2017
Q1
$67.3M Buy
800,300
+262,800
+49% +$21M 0.01% 872
2016
Q4
$39.5M Buy
537,500
+165,700
+45% +$12.3M 0.01% 1171
2016
Q3
$29.8M Buy
371,800
+149,300
+67% +$12M 0.01% 1339
2016
Q2
$17.5M Buy
222,500
+140,800
+172% +$10.6M ﹤0.01% 1697
2016
Q1
$5.88M Sell
81,700
-21,600
-21% -$1.63M ﹤0.01% 2631
2015
Q4
$8.7M Sell
103,300
-195,400
-65% -$16.2M ﹤0.01% 2395
2015
Q3
$25M Buy
298,700
+39,300
+15% +$3.32M 0.01% 1440
2015
Q2
$21.7M Buy
259,400
+195,400
+305% +$14.9M 0.01% 1338
2015
Q1
$4.65M Sell
64,000
-48,900
-43% -$3.48M ﹤0.01% 2538
2014
Q4
$7.79M Sell
112,900
-639,900
-85% -$43.2M ﹤0.01% 2123
2014
Q3
$48.8M Buy
752,800
+45,300
+6% +$2.87M 0.02% 859
2014
Q2
$44M Sell
707,500
-452,600
-39% -$27M 0.01% 894
2014
Q1
$68.3M Sell
1,160,100
-388,500
-25% -$21.7M 0.03% 625
2013
Q4
$79M Buy
1,548,600
+83,900
+6% +$4.2M 0.03% 570
2013
Q3
$73.7M Buy
1,464,700
+710,100
+94% +$37.2M 0.03% 554
2013
Q2
$37.1M Buy
+754,600
New +$41.1M 0.02% 841

Other funds holding LLY

Bank of America's LLY Position: Q1 2026 in Review

Bank of America increased its Eli Lilly (LLY) stake by 0.18% in Q1 2026, buying an estimated $20.5M and bringing the position to 11,125,832 shares worth $10.2B. The position accounts for 0.75% of the portfolio, ranked #22.

Bank of America first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $11.9B in Q4 2025. 4,366 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Bank of America held 11,125,832 shares of Eli Lilly worth $10.2B as of Q1 2026.
  • Bank of America bought 20,246 Eli Lilly shares in Q1 2026, an estimated $20.5M.
  • Eli Lilly made up 0.75% of Bank of America's portfolio in Q1 2026, its #22 holding.
  • Bank of America first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's Eli Lilly position peaked at $11.9B in Q4 2025.
  • 4,366 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.